Discover open access scientific publications

Search, annotate, share and cite publications

Publications by S. Le Gouill

Evaluation of the (R)VAD+C Regimen for the Treatment of Newly Diagnosed Mantle Cell Lymphoma. Combined Results of Two Prospective Phase II Trials From the French GOELAMS Group

Haematologica

Hematology

2010

English

Characteristics and Outcomes of Relapsed Follicular Lymphoma After Autologous Stem Cell Transplantation in the Rituximab Era

Hematological Oncology

English

Safety and Efficacy of Atezolizumab, Obinutuzumab and Venetoclax Combination for Relapsed/Refractory Non-Hodgkin Lymphomas: Results From the Safety-Run of a Lysa Study

Hematological Oncology

English

Increased Ccnd1 Fish Signals Are Associated With Worse Prognosis in Mantle Cell Lymphoma

Hematological Oncology

English

Validation of Real-Time Multiplex Ligation Probe Amplification (Rt-Mlpa) to Analyze Lymphoma Transcriptome From Formalin-Fixed Paraffin Embedded Samples

Hematological Oncology

English

Novel Targeted Strategies to Overcome Microenvironment-Dependent Resistance in Mantle Cell Lymphoma

Hematological Oncology

English

Refinement of Mum1 Expression Threshold for Double Positive Cd10+ Mum1+ Diffuse Large B Cell Lymphoma Allows a Better Cell of Origin Classification for GCB Subtype

Hematological Oncology

English

Interim Report From a Phase 2 Multicenter Study of Tazemetostat, an Ezh2 Inhibitor, in Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas

Hematological Oncology

English

Obinutuzumab Plus Ibrutinib in Relapse/Refractory Mantle Cell Lymphoma Patients: First Results of the Oasis Phase I Trial

Hematological Oncology

English

Obinutuzumab Plus Dhap Followed by Autologous Stem Cell Transplantation (Asct) Plus Obinutuzumab Maintenance Provides a High MRD Response Rate in Untreated MCL Patients. Results of Lyma-101 Trial, a Lysa Group Study

Hematological Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by S. Le Gouill

Evaluation of the (R)VAD+C Regimen for the Treatment of Newly Diagnosed Mantle Cell Lymphoma. Combined Results of Two Prospective Phase II Trials From the French GOELAMS Group

Characteristics and Outcomes of Relapsed Follicular Lymphoma After Autologous Stem Cell Transplantation in the Rituximab Era

Safety and Efficacy of Atezolizumab, Obinutuzumab and Venetoclax Combination for Relapsed/Refractory Non-Hodgkin Lymphomas: Results From the Safety-Run of a Lysa Study

Increased Ccnd1 Fish Signals Are Associated With Worse Prognosis in Mantle Cell Lymphoma

Validation of Real-Time Multiplex Ligation Probe Amplification (Rt-Mlpa) to Analyze Lymphoma Transcriptome From Formalin-Fixed Paraffin Embedded Samples

Novel Targeted Strategies to Overcome Microenvironment-Dependent Resistance in Mantle Cell Lymphoma

Refinement of Mum1 Expression Threshold for Double Positive Cd10+ Mum1+ Diffuse Large B Cell Lymphoma Allows a Better Cell of Origin Classification for GCB Subtype

Interim Report From a Phase 2 Multicenter Study of Tazemetostat, an Ezh2 Inhibitor, in Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas

Obinutuzumab Plus Ibrutinib in Relapse/Refractory Mantle Cell Lymphoma Patients: First Results of the Oasis Phase I Trial

Obinutuzumab Plus Dhap Followed by Autologous Stem Cell Transplantation (Asct) Plus Obinutuzumab Maintenance Provides a High MRD Response Rate in Untreated MCL Patients. Results of Lyma-101 Trial, a Lysa Group Study